Clinical Trials

Lack of Diversity and Participation in Adult Clinical Trials

Several factors have resulted in the lack of diversity and participation in clinical trials for adults with cancer. See more information.

New FDA Approval for RET Positive Medullary Thyroid Cancer

Pralsetinib (Gavreto) is now FDA approved for use in RET mutation-positive medullary thyroid cancer.

Andrew Schorr, Vivek Subbiah, MD

Find a Clinical Trial

Try our Clinical Trial Finder tool. Patient Power has partnered with Antidote to provide you with an easy-to-use tool to assist in your search for clinical trial information. Give the tool a try and if you have any questions, please contact hello@antidote.me.

Latest News

What Does CAR-NK Cell Research Mean for All Cancers?

Andrew Schorr, Katy Rezvani, MD, PhD

Why It’s Important to Consider a Clinical Trial

Lauren Evoy Davis

Why We Need to Increase Diversity in Clinical Trials

Lauren Evoy Davis

How a Delaware Hospital Does Cancer Clinical Trials Right

Kandie Dempsey, DBA, MS, RN, OCN, Andrew Schorr

Clinical Trials: Where Do I Start?

Andrew Schorr

Are Clinical Trials Recommended As an Initial Therapy?

Andy Lee

How Can Clinical Trial Sponsors Help Patients With Cost?

Andy Lee, Andrew Schorr

Are There Clinical Trial Opportunities at the Community Level?

Ken Getz, MBA, Andrew Schorr

How Are Patient Insights Used to Ease Clinical Trial Requirements?

Ken Getz, MBA, Andy Lee, Andrew Schorr

Are Clinical Trials Becoming More Accessible?

Ken Getz, MBA, Andy Lee, T.J. Sharpe, Andrew Schorr

Are Expensive Tests Covered by Medicare in Clinical Trials?

Mark Fleury, PhD, Laura Levaas

Is It Difficult to Participate in a Clinical Trial?

Ken Getz, MBA, Andy Lee, T.J. Sharpe, Andrew Schorr